KUALA LUMPUR: LYC Healthcare Bhd's subsidiary LYC Medicare Singapore Ltd today has lodged the preliminary offer document with the Singapore Exchange Ltd's (SGX) Catalist Board. 

The mother and child care services company said this pivotal step, guided by Evolve Capital Advisory Private Ltd as the sponsor, marks a significant milestone in its strategic expansion and growth trajectory.

The initiative to lodge the offer document for LYC Medicare Singapore highlights LYC Healthcare's adherence to the regulatory standards of SGX. 

"This strategic initiative is anticipated to support further growth and expansion plans for LYC Healthcare, enhancing liquidity and access to capital markets. 

"Additionally, it is anticipated to elevate LYC Healthcare's brand presence in Singapore, fostering greater awareness among consumers and investors in the region," it said. 

LYC Healthcare managing director cum group chief executive officer Sui Dong Hoe said this aligns with the company's vision to strengthen its brand in the Southeast Asian healthcare landscape.

"We are eager to embark on this journey, confident that it will enrich our market presence in Singapore and reinforce our commitment to delivering superior healthcare services across the region," added Sui. 

As at 5pm today, LYC Healthcare's share price closed at 18.5 sen for a total market capitalisation of RM128.1 million.